Table 1 Characteristics of HF according to gender

HFrEF

113 (63.5%)

73 (61.9%)

0.579

Age

59.9 ± 9

65.3 ± 11

0.0001

BMI

29.84 ± 3.2

31.63 ± 4

0.01

Obesity

81 (54.5%)

80 (67.8%)

0.000

DM

74 (41.6%)

45(38.1%)

0.628

HTN

109 (61.2%)

67(56.8%)

0.470

Dyslipidemia

59 (33.1%)

47(39.8%)

0.266

Smoking

120 (67%)

2 (1.7%)

0.000

Previous MI

52 (29.6%)

19 (16.1%)

0.019

Previous PCI

34 (19.1%)

12 (10.2%)

0.043

Prior CABG

18 (10.1%)

8 (6.78%)

0.226

Valve surgery

8 (4.5%)

6 (5.1%)

0.339

Addiction

13 (7.3%)

0 (0%)

0.001

STEMI

22 (12.4%)

16 (14%)

0.329

UA/NSTEMI

16 (9%)

21 (8.5%)

0.878

Cardiogenic shock

39 (22%)

25 (21.2%)

0.351

CHB

3 (1.7%)

1 (0.8%)

0.296

AF/Flutter

16 (8.9%)

25 (21.2%)

0.041

IE

1 (0.6%)

1 (0.8%)

0.916

PE

1 (0.6%)

3 (2.5%)

0.148

Aortic dissection

1 (0.6%)

3 (2.5%)

0.148

Cardiomyopathies

18 (10.1%)

23 (19.5%)

0.011

Chest pain (CP)

35 (19.7%)

25 (21.2%)

0.199

Orthopnea

118 (66%)

80 (67.8%)

0.195

PND

40 (22.5%)

16 (13.6%)

0.040

Palpitations

18 (10.1%)

14 (11.9%)

0.191

Syncope

10 (5.62%)

1 (0.85%)

0.024

Cough

55 (30.9%)

38 (32.2%)

0.704

Edema

63 (35.4%)

38 (32.2%)

0.847

Pacemaker

5 (2.8%)

2 (1.7%)

0.320

ICD

0 (0%)

1 (0.85%)

0.163

Killip class

 I

33 (18.5%)

11 (5.9%)

0.023

 II

8 (4.5%)

6 (5.1%)

0.211

 III

32 (18%)

27(22.8%)

0.119

 IV

102 (57%)

71 (60.2%)

0.176

Pricardiocentesis

3 (1.7%)

1 (0.85%)

0.541

Thazides

22 (12.4%)

8 (6.8%)

0.119

Loop diuretics

109 (61%)

68(57.6%)

0.535

Nitrates

103 (58%)

67 (56.8%)

0.853

Warfarin

63 (35.4%)

31 (26.3%)

0.099

Clopedogril

75 (42.1%)

58 (49.2%)

0.235

Aldesterone antagonist

88 (49.4%)

50 (42.4%)

0.233

Digixon

67 (37.6%)

32 (27.1%)

0.060

Duration of stay

8.71 ± 7

7.06 ± 5

0.020

Mortality

19 (10.7%)

13(11.1%)

0.740

HFpEF

65 (36.5%)

45(38.1%)

0.524

Sepsis

1 (0.6%)

3(2.5%)

0.254

Pneumonia

5 (2.81%)

6 (5.1%)

0.204

AKI

23 (13%)

12 (10.2%)

0.336

CKD/ESRD

7 (4%)

3 (2.5%)

0.291

Resp. failure

0(0%)

4(3.4%)

0.016

liver failure

1(0.6%)

9(7.6%)

0.000

Tamponade

1 (0.6%)

3 (2.5%)

0.254

GIT bleeding

1 (0.6%)

3 (2.5%)

0.148

CCI

167 (93%)

112 (94%)

0.692

Previous MI

54 (30.3%)

17 (14.4%)

0.003

Previous CHF

85 (47.8%)

42 (35.6%)

0.054

PVD

5 (2.8%)

2 (1.7%)

0.296

CVA/TIA

9 (5.1%)

10 (8.5%)

0.167

Hemiplegia

1 (0.6%)

2 (1.7%)

0.220

COPD

15 (8.4%)

10 (8.5%)

0.351

VHD

14 (7.8%)

18(15.2%)

0.020

Peptic ulcer

0 (0%)

1(0.85%)

0.163

Cancer

0 (0%)

1 (0.85%)

0.163

Depression

1 (0.6%)

2 (1.7%)

0.220

Dementia

6 (3.4%)

3 (2.5%)

0.328

Metastasis

1 (0.6%)

3 (2.5%)

0.148

Endotracheal intubation

27 (15.2%)

15 (13%)

0.553

HIV

1 (0.6%)

1 (0.85%)

0.336

Cellulitis

1 (0.6%)

9 (7.6%)

0.000

PCI

20 (11.2%)

7 (6%)

0.021

CRT

3 (1.68%)

2 (1.69%)

0.329

Mechanical ventilation

28 (15.7%)

15 (22%)

0.471

CVP

121 (68%)

71 (60%)

0.168

CA

4 (2.25%)

5 (4.24%)

0.329

DC shock

8 (4.5%)

1 (0.85%)

0.044

Coma

1 (0.6%)

0 (0%)

0.437

Fever

1 (0.6%)

1 (0.85%)

Hemoptysis

0 (0.6%)

1 (0.85%)

Lanoxin toxicisty

0 (0%)

1 (0.85%)

Mechanical ventilation

28 (15.7%)

15(21.7%)

0.471

Amiodarone

17 (9.6%)

7 (14.4%)

0.200

UFH

62(34.8%)

34(28.8%)

0.279

LMWH

100(56.2%)

79 (67%)

0.064

Lytic therapy

45 (25.3%)

32(27.1%)

0.724

ACEI/ARBS

112(62.9%)

78(66.1%)

0.741

Warfarin

22 (12.4%)

22(18.6%)

0.137

Beta-blockers

61 (34.3%)

45 (38%)

0.794

Survivors

159 (89%)

105 (88%)

0.750